Global Lung Cancer Surgery Market Size Study & Forecast, by Instrument, Procedure (Thoracotomy, MIS) and Regional Forecasts 2025-2035

Description

The Global Lung Cancer Surgery Market is valued at approximately USD 6.27 billion in 2024 and is anticipated to grow with a steady CAGR of more than 3.80% over the forecast period 2025-2035. Lung cancer surgery, which is a cornerstone in the treatment of lung malignancies, encompasses a wide range of advanced surgical procedures and devices that allow surgeons to effectively remove cancerous tissue, preserve lung function, and improve patient outcomes. With the rising global burden of lung cancer driven by tobacco consumption, air pollution, occupational hazards, and genetic predispositions, the demand for surgical interventions has continued to surge. Increasing adoption of minimally invasive surgical (MIS) techniques and the integration of advanced monitoring and endoscopic devices have further reshaped the surgical landscape, enabling healthcare providers to deliver safer, faster, and more efficient procedures.

The accelerating prevalence of lung cancer has significantly heightened the necessity for surgical procedures, thereby augmenting the demand for specialized instruments and advanced technologies. According to the World Health Organization, lung cancer remains the leading cause of cancer-related deaths globally, accounting for nearly 1.8 million deaths annually. Technological advancements such as robotic-assisted thoracic surgery, video-assisted thoracoscopic surgery (VATS), and precision-driven surgical tools are creating opportunities for enhanced procedural outcomes and reduced post-operative complications. Moreover, the growing emphasis on early detection programs and government initiatives to improve cancer treatment infrastructure are expected to fuel market expansion. However, high surgical costs, limited access to advanced healthcare facilities in developing regions, and the rising adoption of alternative therapies may hinder the market trajectory during the forecast period.

Regionally, North America accounted for the largest share of the global Lung Cancer Surgery Market in 2025, owing to its highly developed healthcare infrastructure, strong presence of key medical device manufacturers, high prevalence of lung cancer cases, and rapid adoption of cutting-edge surgical technologies. Europe also represents a significant market, driven by favorable reimbursement policies, advanced cancer screening programs, and increased awareness regarding surgical treatment options. Meanwhile, Asia Pacific is poised to witness the fastest growth over the forecast horizon, fueled by surging incidences of lung cancer due to rising smoking rates, rapid urbanization, and growing air pollution levels in densely populated countries such as China and India. Expanding healthcare investments, growing demand for minimally invasive procedures, and the availability of skilled thoracic surgeons further amplify the region's growth potential. Latin America and the Middle East & Africa are also expected to experience steady growth, supported by improvements in healthcare access and rising government spending on cancer treatment initiatives.

Major market player included in this report are:

Medtronic plc
Johnson & Johnson (Ethicon, Inc.)
Olympus Corporation
Siemens Healthineers AG
Intuitive Surgical, Inc.
Boston Scientific Corporation
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Smith & Nephew plc
B. Braun Melsungen AG
KARL STORZ SE & Co. KG
Fujifilm Holdings Corporation
Accuray Incorporated
CONMED Corporation
Terumo Corporation

Global Lung Cancer Surgery Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Instrument:

Clamps
Forceps
Trocars
Retractors
Scissors
Monitoring & Endoscopic Devices

By Procedure:

Thoracotomy
Lobectomy
Pneumonectomy
Segmentectomy
Sleeve Resection
Minimally Invasive Surgery (MIS)

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Lung Cancer Surgery Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Lung Cancer Surgery Market Forces Analysis

3.1. Market Forces Shaping The Global Lung Cancer Surgery Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising lung cancer incidence and expansion of LDCT screening programs increasing surgical candidacy
- 3.2.2. Adoption of minimally invasive and robotic-assisted thoracic surgery improving outcomes and throughput
3.3. Restraints
- 3.3.1. High procedure and device costs with limited access to advanced surgical infrastructure in developing regions
- 3.3.2. Shift toward targeted and immuno-oncology therapies reducing surgical volumes in select patient cohorts
3.4. Opportunities
- 3.4.1. Technological innovation (AI-guided imaging, 3D planning, patient-specific instruments, ERAS protocols)
- 3.4.2. APAC capacity build-out amid urbanization and pollution burden, creating new demand pockets

Chapter 4. Global Lung Cancer Surgery Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Lung Cancer Surgery Market Size & Forecasts by Instrument 2025-2035

5.1. Market Overview
5.2. Global Lung Cancer Surgery Market Performance - Potential Analysis (2025)
5.3. Clamps
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Forceps
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Trocars
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Retractors
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
5.7. Scissors
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035
5.8. Monitoring & Endoscopic Devices
- 5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.8.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Lung Cancer Surgery Market Size & Forecasts by Procedure 2025-2035

6.1. Market Overview
6.2. Global Lung Cancer Surgery Market Performance - Potential Analysis (2025)
6.3. Thoracotomy
- 6.3.1. Lobectomy
  - 6.3.1.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
  - 6.3.1.2. Market size analysis, by region, 2025-2035
- 6.3.2. Pneumonectomy
  - 6.3.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
  - 6.3.2.2. Market size analysis, by region, 2025-2035
- 6.3.3. Segmentectomy
  - 6.3.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
  - 6.3.3.2. Market size analysis, by region, 2025-2035
- 6.3.4. Sleeve Resection
  - 6.3.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
  - 6.3.4.2. Market size analysis, by region, 2025-2035
6.4. Minimally Invasive Surgery (MIS)
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Lung Cancer Surgery Market Size & Forecasts by Region 2025-2035

7.1. Lung Cancer Surgery Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Lung Cancer Surgery Market
- 7.3.1. U.S. Lung Cancer Surgery Market
  - 7.3.1.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Procedure breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Lung Cancer Surgery Market
  - 7.3.2.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Procedure breakdown size & forecasts, 2025-2035
7.4. Europe Lung Cancer Surgery Market
- 7.4.1. UK Lung Cancer Surgery Market
  - 7.4.1.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Procedure breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Lung Cancer Surgery Market
  - 7.4.2.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Procedure breakdown size & forecasts, 2025-2035
- 7.4.3. France Lung Cancer Surgery Market
  - 7.4.3.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Procedure breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Lung Cancer Surgery Market
  - 7.4.4.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Procedure breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Lung Cancer Surgery Market
  - 7.4.5.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Procedure breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Lung Cancer Surgery Market
  - 7.4.6.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Procedure breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Lung Cancer Surgery Market
- 7.5.1. China Lung Cancer Surgery Market
  - 7.5.1.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Procedure breakdown size & forecasts, 2025-2035
- 7.5.2. India Lung Cancer Surgery Market
  - 7.5.2.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Procedure breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Lung Cancer Surgery Market
  - 7.5.3.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Procedure breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Lung Cancer Surgery Market
  - 7.5.4.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Procedure breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Lung Cancer Surgery Market
  - 7.5.5.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Procedure breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Lung Cancer Surgery Market
  - 7.5.6.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Procedure breakdown size & forecasts, 2025-2035
7.6. Latin America Lung Cancer Surgery Market
- 7.6.1. Brazil Lung Cancer Surgery Market
  - 7.6.1.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Procedure breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Lung Cancer Surgery Market
  - 7.6.2.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Procedure breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Lung Cancer Surgery Market
- 7.7.1. UAE Lung Cancer Surgery Market
  - 7.7.1.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Procedure breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Lung Cancer Surgery Market
  - 7.7.2.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Procedure breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Lung Cancer Surgery Market
  - 7.7.3.1. Instrument breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Procedure breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Medtronic plc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Johnson & Johnson (Ethicon, Inc.)
8.4. Olympus Corporation
8.5. Siemens Healthineers AG
8.6. Intuitive Surgical, Inc.
8.7. Boston Scientific Corporation
8.8. Zimmer Biomet Holdings, Inc.
8.9. Stryker Corporation
8.10. Smith & Nephew plc
8.11. B. Braun Melsungen AG
8.12. KARL STORZ SE & Co. KG
8.13. Fujifilm Holdings Corporation
8.14. Accuray Incorporated
8.15. CONMED Corporation
8.16. Terumo Corporation